SEOM临床指南:软组织肉瘤的治疗

2021-02-01 西班牙医学肿瘤学会( Spanish Society of Medical Oncology) Clin Transl Oncol . 2021 Jan 6.

软组织肉瘤是间充质起源的肿瘤的罕见和异质性组。 诊断,治疗和管理应由专业的多学科团队进行。 在进行任何治疗之前,必须对原发肿瘤进行MRI / CT和活检。 具有无肿瘤组织边缘的广泛手术切除是局部疾病的

中文标题:

SEOM临床指南:软组织肉瘤的治疗

英文标题:

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

发布日期:

2021-02-01

简要介绍:

软组织肉瘤是间充质起源的肿瘤的罕见和异质性组。 诊断,治疗和管理应由专业的多学科团队进行。 在进行任何治疗之前,必须对原发肿瘤进行MRI / CT和活检。 具有无肿瘤组织边缘的广泛手术切除是局部疾病的主要手段。 放射治疗适用于大,深,高级别的肿瘤,或不适合再次切除的边缘切除术后。 对于四肢和躯干壁的高危肉瘤,应讨论围手术期化疗。 对于少转移性疾病,应考虑对患者进行局部治疗。 选择用蒽环类药物(或联合异环磷酰胺)进行一线治疗。 其他药物在二线治疗和特定的组织学亚型中已显示出活性,但选择受限,因此,应始终讨论临床试验。

相关资料下载:
[AttachmentFileName(sort=1, fileName=Managem.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cafa41c0020590f4, title=SEOM临床指南:软组织肉瘤的治疗, enTitle=SEOM Clinical Guideline of management of soft-tissue sarcoma (2020), guiderFrom=Clin Transl Oncol . 2021 Jan 6., authorId=0, author=, summary=软组织肉瘤是间充质起源的肿瘤的罕见和异质性组。 诊断,治疗和管理应由专业的多学科团队进行。 在进行任何治疗之前,必须对原发肿瘤进行MRI / CT和活检。 具有无肿瘤组织边缘的广泛手术切除是局部疾病的, cover=, journalId=0, articlesId=null, associationId=1918, associationName=西班牙医学肿瘤学会( Spanish Society of Medical Oncology), associationIntro= Spanish Society of Medical Oncology, copyright=0, guiderPublishedTime=Mon Feb 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">软组织肉瘤是间充质起源的肿瘤的罕见和异质性组。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="1">诊断,治疗和管理应由专业的多学科团队进行。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="2">在进行任何治疗之前,必须对原发肿瘤进行MRI / CT和活检。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="3">具有无肿瘤组织边缘的广泛手术切除是局部疾病的主要手段。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="4">放射治疗适用于大,深,高级别的肿瘤,或不适合再次切除的边缘切除术后。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="5">对于四肢和躯干壁的高危肉瘤,应讨论围手术期化疗。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="6">对于少转移性疾病,应考虑对患者进行局部治疗。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="7">选择用蒽环类药物(或联合异环磷酰胺)进行一线治疗。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="8">其他药物在二线治疗和特定的组织学亚型中已显示出活性,但选择受限,因此,应始终讨论临床试验。</span></span></p>, tagList=[TagDto(tagId=2794, tagName=软组织肉瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2500, appHits=330, showAppHits=0, pcHits=547, showPcHits=2170, likes=7, shares=17, comments=23, approvalStatus=1, publishedTime=Sat Feb 13 21:12:43 CST 2021, publishedTimeString=2021-02-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=fbzhang, createdTime=Sat Feb 13 20:48:44 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 14:25:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=Managem.pdf)])
Managem.pdf
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1234447, encodeId=4889123444e4e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:48:11 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069061, encodeId=76091069061c2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0d20efa54fee49fba0580eddbd3866c6/3e960aa8346342ec837310996af96e30.jpg, createdBy=ebea5209167, createdName=严谨yyy, createdTime=Wed Nov 10 20:11:01 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058354, encodeId=302b1058354c7, content=这是最新版的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=830f2464103, createdName=Bureaukey, createdTime=Thu Oct 07 14:33:13 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053838, encodeId=efaa1053838a4, content=指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aed2506225, createdName=124acf90m64暂无昵称, createdTime=Wed Sep 22 16:28:19 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014549, encodeId=2127101454988, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70b14719205, createdName=luqing880816, createdTime=Sat Sep 04 15:14:15 CST 2021, time=2021-09-04, status=1, ipAttribution=)]
    2022-07-24 1471d48dm72暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1234447, encodeId=4889123444e4e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:48:11 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069061, encodeId=76091069061c2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0d20efa54fee49fba0580eddbd3866c6/3e960aa8346342ec837310996af96e30.jpg, createdBy=ebea5209167, createdName=严谨yyy, createdTime=Wed Nov 10 20:11:01 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058354, encodeId=302b1058354c7, content=这是最新版的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=830f2464103, createdName=Bureaukey, createdTime=Thu Oct 07 14:33:13 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053838, encodeId=efaa1053838a4, content=指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aed2506225, createdName=124acf90m64暂无昵称, createdTime=Wed Sep 22 16:28:19 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014549, encodeId=2127101454988, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70b14719205, createdName=luqing880816, createdTime=Sat Sep 04 15:14:15 CST 2021, time=2021-09-04, status=1, ipAttribution=)]
    2021-11-10 严谨yyy

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1234447, encodeId=4889123444e4e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:48:11 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069061, encodeId=76091069061c2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0d20efa54fee49fba0580eddbd3866c6/3e960aa8346342ec837310996af96e30.jpg, createdBy=ebea5209167, createdName=严谨yyy, createdTime=Wed Nov 10 20:11:01 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058354, encodeId=302b1058354c7, content=这是最新版的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=830f2464103, createdName=Bureaukey, createdTime=Thu Oct 07 14:33:13 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053838, encodeId=efaa1053838a4, content=指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aed2506225, createdName=124acf90m64暂无昵称, createdTime=Wed Sep 22 16:28:19 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014549, encodeId=2127101454988, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70b14719205, createdName=luqing880816, createdTime=Sat Sep 04 15:14:15 CST 2021, time=2021-09-04, status=1, ipAttribution=)]
    2021-10-07 Bureaukey

    这是最新版的吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1234447, encodeId=4889123444e4e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:48:11 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069061, encodeId=76091069061c2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0d20efa54fee49fba0580eddbd3866c6/3e960aa8346342ec837310996af96e30.jpg, createdBy=ebea5209167, createdName=严谨yyy, createdTime=Wed Nov 10 20:11:01 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058354, encodeId=302b1058354c7, content=这是最新版的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=830f2464103, createdName=Bureaukey, createdTime=Thu Oct 07 14:33:13 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053838, encodeId=efaa1053838a4, content=指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aed2506225, createdName=124acf90m64暂无昵称, createdTime=Wed Sep 22 16:28:19 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014549, encodeId=2127101454988, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70b14719205, createdName=luqing880816, createdTime=Sat Sep 04 15:14:15 CST 2021, time=2021-09-04, status=1, ipAttribution=)]
    2021-09-22 124acf90m64暂无昵称

    指南

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1234447, encodeId=4889123444e4e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:48:11 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069061, encodeId=76091069061c2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0d20efa54fee49fba0580eddbd3866c6/3e960aa8346342ec837310996af96e30.jpg, createdBy=ebea5209167, createdName=严谨yyy, createdTime=Wed Nov 10 20:11:01 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058354, encodeId=302b1058354c7, content=这是最新版的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=830f2464103, createdName=Bureaukey, createdTime=Thu Oct 07 14:33:13 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053838, encodeId=efaa1053838a4, content=指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aed2506225, createdName=124acf90m64暂无昵称, createdTime=Wed Sep 22 16:28:19 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014549, encodeId=2127101454988, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70b14719205, createdName=luqing880816, createdTime=Sat Sep 04 15:14:15 CST 2021, time=2021-09-04, status=1, ipAttribution=)]
    2021-09-04 luqing880816

    谢谢

    0